SCHEMBL28670321

SCHEMBL28670321

CCC(N)CCCCCC1CC(=O)N(O)C1=O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27576345 0.81 CYP1A2 (0.40) CYP2C19
SCHEMBL1758179 0.79 CYP1A2 (0.38) CYP2C19
SCHEMBL13003189 0.77 ELANE (0.37) CYP2C19
SCHEMBL15264476 0.73 KMT2A (0.33) CYP2C19
SCHEMBL19619374 0.71 FAAH (0.32)
SCHEMBL25215380 0.71 ACE (0.34)
SCHEMBL8228528 0.69 CYP2C19 (0.44) CYP2C19
SCHEMBL1133829 0.68 ALDH1A1 (0.40)
SCHEMBL7963629 0.65 MME (0.55) CYP2C19
SCHEMBL7049167 0.65 PLA2G1B (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115702159-A NGR conjugates and uses thereof 圣拉斐尔医院有限公司 2023-02-14 CN disclosed
CN-113597304-A Combination therapy for primary central nervous system lymphoma 圣拉斐尔基金会中心 2021-11-02 CN disclosed